A Phase 1 Study to Evaluate the Pharmacokinetics and Safety of Cabotegravir in Patients With Hepatic Impairment and Healthy Matched Controls.

A Phase 1 Study to Evaluate the Pharmacokinetics and Safety of Cabotegravir in Patients With Hepatic Impairment and Healthy Matched Controls. — المؤلف: Shaik, Jafar Sadik B — Clinical pharmacology in drug development 20200713

المؤلف
Shaik, Jafar Sadik B
النشر
Clinical pharmacology in drug development 20200713
الوصف
664-673 p.
الموضوعات
Administration, Oral؛ Anti-HIV Agents؛ Female؛ Hepatic Insufficiency؛ Humans؛ Male؛ Middle Aged؛ Pyridones